Bill > H1307

This bill proposes an amendment to Section 47W of Chapter 175 that would require a blood test screening for Factor V Leiden (FVL), a genetic mutation that increases the risk of blood clots, to be performed before a person can be prescribed pharmacological contraceptive methods. Factor V Leiden is a genetic condition that makes blood more likely to clot, which can potentially increase the risk of dangerous blood clotting when combined with certain hormonal contraceptives. The bill mandates that this screening test must be conducted prior to prescribing any pharmacological contraceptive methods, regardless of existing laws that might otherwise apply. This requirement appears designed to provide an additional layer of medical screening to help prevent potential health risks for individuals seeking hormonal contraception, particularly for those who might have an undiagnosed genetic predisposition to blood clotting disorders.

Business and Industry

https://malegislature.gov/Bills/194/H1307